Geron (GERN) Competitor Comparison
We are evaluating the key criteria listed to compare Geron (GERN) against its competitors in the Biotechnology industry.
Market Capitalization
121 / 368Gross Profits
235 / 278Total Revenue
262 / 300EBITDA
277 / 337Free Cashflow
285 / 352Quick Ratio
239 / 357Earnings per Share
67 / 359Dividend yield
0 / 6Total Cash
106 / 358Performance 3 years
35 / 368Performance 5 years
56 / 368Performance 10 years
94 / 368Linearity 3 years
312 / 368Linearity 5 years
333 / 368Linearity 10 years
30 / 368Total Rank
319 / 368Dividend Rank
140 / 368Valuation Rank
358 / 368Piotroski Rank
282 / 368Muliplier Rank
350 / 368Total Cash - GERN ranking 106 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.